In vivo ViroMag
In vivo ViroMag Transfection Reagent has been designed for in vivo targeted transduction with any viral vector. Virus/nanoparticles complexes can be easily administrated through various injection routes such as systemic administration (intravenous, intra-artery) or local administration (intratumoral, intracerebroventricular).
In vivo Magnetofection™ main advantages in comparison to other procedures:
-
High and increased transduction / infection efficiency
-
Magnetically targeted transduction to specific area
-
Reduction of virus dose and systemic dissemination
-
Work under non permissive conditions (hypothermia, physiological flow conditions)
-
Penetration of the vector into tissues
-
Minimized toxicity
-
Suitable for all types of viruses
Sizes:
-
250 µL
-
500 µL
Storage: +4°C
Shipping Conditions: Room temperature
- NB: This reagents needs to be used with a magnet.
Catalog number | Unit Size | Price excl tax | Quantity / Buy |
IV-TK30230 |
Trial kit: 50µL reagent + 1 cylinder magnet
|
$140.00
|
|
IV-KC30230 |
Starting kit: 250 µL reagent + Magnets set
|
$410.00
|
|
IV-VM30250 |
250 µL
|
$329.00
|
|
IV-VM30500 |
500 µL
|
$580.00
|
|
Citation database
NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
Aortic root | Retrovirus/Lentivirus | in vivo ViroMag | Burdorf L. Xenotransplantation. 2007; 14(1):372. | |
BHK-21 | SF Virus | in vivo ViroMag | Kurena B. J Virol Methods. 2017 Mar 14. pii: S0166-0934(17)30089-7. | |
in vivo: Aortic root | Retrovirus/Lentivirus | in vivo ViroMag | Burdorf L. Xenotransplantation. 2007; 14(1):372. | |
in vivo: Brain | LentiVirus | in vivo ViroMag | Schubert R. Nat Protoc. 2019 Oct 18. doi: 10.1038/s41596-019-0221-z. | |
in vivo: Brain | LentiVirus | in vivo ViroMag | Schubert R. Nat Biotechnol. 2017 Dec 18. doi: 10.1038/nbt.4034. | |
TS/A | SF Virus | in vivo ViroMag | Kurena B. J Virol Methods. 2017 Mar 14. pii: S0166-0934(17)30089-7. |
Related products